Marshall Wace’s Milestone Pharmaceuticals MIST Stock Holding History

Marshall Wace’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Sell	1,797,695 -146,835	-8%	-$235K	﹤0.01%	1752
2026 Q1	$2.31M	Buy	1,944,530 +287,709	+17%	+$504K	﹤0.01%	1702
2025 Q4	$3.35M	Buy	1,656,821 +1,231,793	+290%	+$2.65M	﹤0.01%	1334
2025 Q3	$850K	Buy	+425,028	New	+$747K	﹤0.01%	2011
2023 Q4	–	Sell	-113,187	Closed	-$351K	–	2445
2023 Q3	$351K	Sell	113,187 -53,914	-32%	-$168K	﹤0.01%	1829
2023 Q2	$476K	Sell	167,101 -65,391	-28%	-$247K	﹤0.01%	2008
2023 Q1	$916K	Sell	232,492 -189,048	-45%	-$691K	﹤0.01%	1864
2022 Q4	$1.67M	Buy	421,540 +390,642	+1,264%	+$2.06M	﹤0.01%	1823
2022 Q3	$284K	Buy	+30,898	New	+$234K	﹤0.01%	2974

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Marshall Wace's MIST Position: Q2 2026 in Review

Marshall Wace reduced its Milestone Pharmaceuticals (MIST) stake by 7.6% in Q2 2026, selling an estimated $235K and leaving 1,797,695 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

Marshall Wace first reported a position in MIST in Q3 2022 and has held it in 9 quarters since. The position peaked at $3.35M in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Marshall Wace held 1,797,695 shares of Milestone Pharmaceuticals worth $2.41M as of Q2 2026.
Marshall Wace sold 146,835 Milestone Pharmaceuticals shares in Q2 2026, an estimated $235K.
Milestone Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1752 holding.
Marshall Wace first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
Marshall Wace's Milestone Pharmaceuticals position peaked at $3.35M in Q4 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.